Eli Lilly and Company & Marvell Technology
3 shared events · Importance 3 · Last updated Jun 11, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Business
Eli Lilly and Company: Eli Lilly and Company>>> advanced after positive trial results for its next-generation obesity drug, retatrutide, which showed benefits beyond weight loss.
Marvell Technology: Marvell Technology>>> saw a significant jump in its stock price as it was set to join the S&P 500>>>, signaling increased investor confidence and market recognition.
May 20, 2026 · 66 articles
International
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
Marvell Technology: Marvell Technology>>> rose after UBS>>> raised its target price, reflecting investor confidence in its performance.
May 18, 2026 · 309 articles
International
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
Marvell Technology: Marvell Technology>>> rose after UBS>>> raised its target price, reflecting investor confidence in its performance.
May 27, 2026 · 101 articles
NEWSDESK
Explore this relationship live
Track how Eli Lilly and Company and Marvell Technology interact across events, view sentiment trends, and discover connected entities.
Open Dashboard